What do sulfonylurea hypoglycemic drugs have?

summary

Sulfonylureas are one of the earliest oral hypoglycemic drugs. Now sulfonylureas have developed to the third generation. Each generation of sulfonylureas has certain efficacy. However, due to the clinical effect, the second generation of sulfonylureas has gradually replaced the first generation, The hypoglycemic reaction of the second generation of sulfonylurea hypoglycemic drugs is relatively small, and it is particularly safe for patients to eat, especially for patients with type 2 diabetes who choose the second generation of sulfonylurea drugs to treat diseases.

What do sulfonylurea hypoglycemic drugs have?

Gliclazide Sustained release tablets, glimepiride, glibenclamide and tolbutamide are sulfonylureas, hypoglycemic drugs. There are some differences in the pharmacokinetics and pharmacodynamics of various sulfonylureas. Therefore, when people treat different types of diabetes, they will choose different sulfonylureas for treatment.

Glibenclamide, a hypoglycemic drug, is actually the second generation of sulfonylureas. The efficacy of glibenclamide is particularly strong, and through clinical practice, its effect lasts for the longest time. This hypoglycemic drug will have effect after 20 minutes of oral administration.

If people use glibenclamide, a sulfonylurea drug, to treat diseases, they can take it orally half an hour before eating. People can take about 2.5 mg each time. If people want to increase the dosage of glibenclamide, the maximum dosage is 5 mg each time.

matters needing attention

Glipizide, a sulfonylurea drug, takes effect very quickly when it is taken. It takes about 30 minutes to take effect, but there are still many side effects. After taking it, people will feel nervous, and their bodies will be weak.